Lab1636 — Harvard–Deerfield R&D Alliance
Supports collaboration between Harvard and Deerfield to advance novel therapeutic discoveries toward clinical validation for patient impact.
Lab1636 is a major strategic translational research alliance between Harvard University and Deerfield Management, a healthcare-focused investment firm, established to catalyze the development of novel therapeutics and rapidly drive Harvard biomedical innovations toward clinical validation. Deerfield Management committed $100 million to establish the alliance, making Lab1636 one of the largest indu…
Drug discovery and development of novel therapeutics for biomedical conditions, targeting clinical validation through the $100M Harvard–Deerfield translational research alliance.
Sign up free to see the funding breakdown
Sign up free to see the industries in scope
Sign up free to see the full eligibility
Sign up free to see how to apply
Sign up free to see what you submit
Sign up free to see the timeline